207 results on '"Chhetri, Rakchha"'
Search Results
2. TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms
3. Allogeneic hematopoietic stem cell transplant outcomes in adults with inherited myeloid malignancies
4. IDH-mutant myeloid neoplasms are associated with seronegative rheumatoid arthritis and innate immune activation
5. Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancer
6. IDH-mutant myeloid neoplasms are associated with seronegative rheumatoid arthritis and innate immune activation
7. Respiratory Viruses Cause Late Morbidity in Recipients of Hematopoietic Stem Cell Transplantation
8. Comprehensive geriatric assessment predicts azacitidine treatment duration and survival in older patients with myelodysplastic syndromes
9. The mutational burden of therapy-related myeloid neoplasms is similar to primary myelodysplastic syndrome but has a distinctive distribution
10. A Personalized Risk Model for Azacitidine Outcome in Myelodysplastic Syndrome and Other Myeloid Neoplasms Identified by Machine Learning Model Utilizing Real-World Data
11. Personalized risk model for predicting risk of acute coronary syndrome in patients with myelodysplastic syndromes
12. Incidence of Decreased Bone Mineral Density Post Allogeneic Haemopoietic Stem Cell Transplant: Single Institution Retrospective Analysis
13. Comparable Survival Following Allogeneic Haematopoietic Stem Cell Transplant Utilising HLA-Matched Vs Alternative Donors: A Single-Centre Retrospective, Consecutive Cohort Analysis
14. Seronegative Rheumatoid Arthritis and Innate Immune Activation is Frequent in Myeloid Neoplasms with Isocitrate Dehydrogenase 1/2 Mutations
15. TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype
16. TP53 Mutation Status Defines a Distinct Clinicopathological Entity of Therapy-Related Myeloid Neoplasm, Characterized By Genomic Instability and Extremely Poor Outcome
17. Characteristics and Outcomes of Radiation Therapy-Related Myeloid Neoplasms
18. Comparable Survival Following Allogeneic Haematopoietic Stem Cell Transplant Utilising HLA-Matched Versus Alternative Donors: A Single-Centre Retrospective, Consecutive Cohort Analysis
19. Integrated Personalized Prediction Model Identifies a Subgroup of Wild-Type TP53therapy-Related Myeloid Neoplasm Patients with Poor Outcome
20. Personalized Prediction Model to Risk Stratify Patients with Therapy-Related Myeloid Neoplasms
21. Allogeneic Hematopoietic Stem Cell Transplant Outcomes in Adults with Inherited Myeloid Malignancies
22. TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype
23. Outcomes following venetoclax‐based treatment in therapy‐related myeloid neoplasms
24. Factors Predicting Survival Following Allogeneic Stem Cell Transplant in Patients with Therapy-Related Myeloid Neoplasms
25. Frequency of Chromosomal Translocations Are Significantly Higher in Therapy Related Myeloid Neoplasm As Compared to Primary MDS
26. Hypomethylating Therapy Does Not Improve Outcome of Therapy-Related Myeloid Neoplasm Including TP53 Mutated and Complex Karyotype Subgroups
27. Unexpected High Frequency of Pathogenic Germline Variants in Older Adults with Primary Myelodysplastic Syndrome
28. Outcome of Therapy-Related Myeloid Neoplasms with Venetoclax-Based Therapy
29. T-MDS Is a Distinct Clinical and Pathological Entity Characterized By Better Survival Compared to t-AML
30. High Prevalence of IDH Mutation in Myeloid Neoplasm with Concomitant Autoimmune Rheumatic Disorders
31. Single-Hit TP53mut Is Associated with Poor Outcomes in Therapy-Related but Not De Novo Myelodysplastic Syndromes: Importance of Clinical History
32. TP53mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype
33. Clinical Effectiveness of Conjugate Pneumococcal Vaccination in Hematopoietic Stem Cell Transplantation Recipients
34. Screening for deficits using the G8 and VES-13 in older patients with Myelodysplastic syndromes
35. 309 - Comparable Survival Following Allogeneic Haematopoietic Stem Cell Transplant Utilising HLA-Matched Vs Alternative Donors: A Single-Centre Retrospective, Consecutive Cohort Analysis
36. Therapy-Related Myeloid Neoplasm Has a Distinct Pro-Inflammatory Bone Marrow Microenvironment and Delayed DNA Damage Repair
37. Burden of Cardiovascular Events and Bleeding Is High in Myelodysplastic Syndromes
38. The burden of immune‐mediated refractoriness to platelet transfusions in myelodysplastic syndromes
39. 166 - Factors Predicting Survival Following Allogeneic Stem Cell Transplant in Patients with Therapy-Related Myeloid Neoplasms
40. Deleterious Germline Variants, Especially in the DNA Repair Pathway, Are Common in Patients with Non-Related Multiple Cancers, One of Them Being Hematological Malignancy
41. An Observational Study of the Prescribing Practices and Patient Reported Outcomes Measures in Older People with Myelodysplastic Syndrome
42. Aberrant Bone Marrow Microenvironment in Therapy Related Myeloid Neoplasm (t-MN)
43. The Burden of Clinically Significant Bleeding, Thrombocytopenia and Platelet Transfusions in Myelodysplastic Syndromes
44. FRI0016 MUTATIONAL LANDSCAPE OF MYELODYSPLASTIC SYNDROME IN PATIENTS WITH AUTOIMMUNE RHEUMATOLOGICAL DISORDERS
45. Red cell autoimmunization and alloimmunization in myelodysplastic syndromes: prevalence, characteristic and significance
46. The Mutation Profile of Myelodysplastic Syndrome Associated with Auto-Immune Rheumatological Disorders
47. Genetic Predisposition to Therapy-Related Myeloid Neoplasm By Rare, Deleterious Germline Variants in DNA Repair Pathway and Myeloid Driver Genes
48. Geriatric Assessment in Older People with Myelodysplasia Is Predictive of Azacitidine Therapy Completion and Survival: A Prospective Interventional Study at the Royal Adelaide Hospital
49. Causative Organisms and Resistance Patterns of Infection in Patients with Myelodysplastic Syndrome (MDS): A 20 Year Retrospective Analysis
50. Red Cell Alloimmunisation Is Associated with Increased Red Cell Transfusion Requirements in Myelodysplastic Syndrome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.